NORONEX LIMITED — Director's Dealing 2024

May 19, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Noronex Limited
ABN	609 594 005

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Piers Lewis
Date of last notice	31 October 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	CRANLEY CONSULTING PTY LTD
Date of change	20 May 2024
No. of securities held prior to change	• 3,041,667 fully paid ordinary shares; • 1,500,000 unquoted options exercisable at $0.075 each on or before 9 February 2025; • 304,167 quoted options exercisable at $0.025each on or before7August 2026
Class	1. Unquoted options exercisable at $0.014 each on or before 20 May 2024 2. Fully Paid Ordinary Shares
Number acquired	1. 1,817,830 2. 1,635,660
Number disposed	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	1. Nil, free attaching placement options and incentive options. 2. $14,066.66
No. of securities held after change	• 4,677,327 fully paid ordinary shares; • 1,500,000 unquoted options exercisable at $0.075 each on or before 9 February 2025; • 304,167 quoted options exercisable at $0.025 each on or before 7 August 2026; • 1,817,830 unquoted options exercisable at $0.014 each on or before 20 May 2027
Nature of change Example: on-market trade, of-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Participation in placement and grant of incentive options. Refer to Notice of Meetingdated 19April 2024.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
**Date of change **	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
**Interest after change **	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow N/A the trade to proceed during this period?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

If prior written clearance was provided, on what date N/A was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3